Mike Alkire, president of Premier Purchasing Partners Inc., on healthcare reform and nationally recognized initiatives leading the way to help solve this pressing problem.
While not all diseases are vaccine-preventable, new vaccines have the potential to radically change medical treatment by treating pre-existing conditions such as HIV, cancer, multiple sclerosis, shingles and Alzheimer's.
Former public health physician, Dr. Vas Narasimhan has a personal passion for eradicating vaccine-preventable diseases and makes it a point to lead by example in his role as head of vaccines, Novartis North America.
Living with a rare bleeding disorder, Jennifer Wakefield has found meaning and purpose helping others cope with chronic illness.
This issue looks at ongoing vulnerabilities in the healthcare supply chain and meaningful measures to prevent drug counterfeiting.
For many, the 2009 H1N1 pandemic is just headline news. But when become a statistic, vaccine compliance hits much closer to home.
President of Octapharma USA Flemming Nielsen discusses encouraging innovation, prioritizing safety and leading by example.
This issue presents a patient-focused perspective on understanding how pharmaceutical advances have improved the quality of life for patients.
In his role as chairman and CEO of Talecris, an industry-leading global provider of plasma-derived protein therapies, Lawrence Stern emphasizes flexibility, adaptability, communication and teamwork.
From increasing access and expanding vaccine efforts and improving the supply chain, innovation is at the heart of improving healthcare.
For many, seasonal flu signifies aches, pains and fever, plus a few missed days at work or school. But for approximately 36,000 Americans each year, influenza is a serious, fatal, yet preventable disease that claims victims of all ages.
CSL Behring President Peter Turner is both an inspired and inspirational leader, equally comfortable in his roles as corporate visionary and roll-up-your-sleeves team builder.